Nazione: Malta
Lingua: inglese
Fonte: Medicines Authority
AMANTADINE SULFATE
Merz Pharmaceuticals GmbH Eckenheimer Landstrasse 100, D-60318 Frankfurt am Main, Germany
N04BB01
AMANTADINE SULFATE 100 mg
FILM-COATED TABLET
AMANTADINE SULFATE 100 mg
POM
ANTI-PARKINSON DRUGS
Withdrawn
2006-11-07
PK-Merz ` Film-coated tablets AMANTADINE SULPHATE Direction for use, please read carefully! Composition: One film-coated tablet contains: Active ingredient: Amantadine sulphate 100 mg. Excipients: Lactose monohydrate, microcrystalline cellulose, potato starch, gelatine, povidone, talc, colloidal silicon dioxide, magnesium stearate, croscarmellose sodium, eudragit E, yellow-orange S and titanium dioxide. Indications: PK-Merz film-coated tablet is effective against all symptoms of Parkinson’s disease such as rigidity, tremor and hypo- or akinesia as well as against residual symptoms and complaints after stereotactic operations. Contra-indications: PK-Merz film-coated tablets must not be used in patients with: – hypersensitivity to amantadine or to any of the other constituents of the medicinal product, – severe non compensated heart insufficiency (stage NYHA IV), – cardiomyopathies and myocarditis (disease of the cardiac muscles), – grade II or III AV-block, – existing bradycardia under 55 beats/min, – known prolonged QT interval (Bazett QTc > 420 ms) or discernible U-waves or congenital QT syndrome in the family anamnesis, – history of serious ventricular arrhythmias including torsades de pointes and – low blood level of calcium and magnesium. PK-Merz film-coated tablets must not be used in patients simultaneous treatment with budipine or other drugs that prolong the QT interval (see interactions). PK-Merz film-coated tablets should not be used in: – severe renal impairment (creatinine clearance < 10 ml/min). PK-Merz film-coated tablets may be used only with particular caution in patients with: – prostate hypertrophy, – narrow angle glaucoma, – kidney failure (of varying severity; risk of accumulation due to deterioration in renal filtration performance, – states of agitation or confusion and – delirious syndromes or exogenous psychosis in the anamnesis. PK-Merz film-coated tablets may be administered simultaneously with memantine with caution. Pregnancy and lactat Leggi il documento completo
Page 1 of 11 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT PK-Merz 100 mg film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance: amantadine sulphate. Each film-coated tablet contains 100 mg of amantadine sulphate. Excipients: Yellow Orange S (E110): see also chapter 4.4. For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Film-coated tablet. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS - Parkinsonian syndromes: treatment of symptoms of Parkinson’s disease such as rigor, tremor, hypokinesia and akinesia. - Extrapyramidal side effects of neuroleptics and other drugs with similar modes of action, such as early dyskinesia, akathisia and parkinsonism. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION DOSAGE WITH SINGLE AND DAILY DOSES: An ECG (50 mm/s) should be recorded before and 1 and 3 weeks after commencing treatment and the Bazett frequency-corrected QT time (QTc) determined manually. Such an ECG should also be recorded before and 2 weeks after any subsequent dose increase. Further ECG check-ups should then take place at least once a year. Treatment must be avoided or discontinued in patients who show baseline QTc values above 420 ms, an increase of more than 60 ms during treatment with PK-Merz 100 mg film-coated tablets, or a QTc in excess of 480 ms during treatment with PK-Merz 100 mg film-coated tablets, and in patients who show discernible U waves. By following the above precautions and taking the contraindications listed in section 4.3 into account, the very rare, but life-threatening, side Leggi il documento completo